ADC Therapeutics (ADCT) Current Taxes (2019 - 2022)

ADC Therapeutics (ADCT) has reported Current Taxes for 4 consecutive years, with $799000.0 the latest figure, recorded in Q2 2022.

• Quarterly Current Taxes rose 237.13% year-over-year to $799000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $799000.0 (up 237.13% YoY) and the FY2021 annual result came in at $3.8 million, up 2419.46% from the prior year.
• Current Taxes declined to $799000.0 in Q2 2022 per ADCT's latest filing, from $6.4 million in the prior quarter.
• Over the last five years, Current Taxes for ADCT reached as high as $6.4 million in Q1 2022 and fell as low as $52000.0 in Q4 2019.
• A 4-year average of $1.7 million and a median of $237000.0 in 2021 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2020 — Current Taxes soared 186.54% — and 2022, when it soared 2591.98%.
• Year by year, Current Taxes stood at $52000.0 in 2019, then surged by 186.54% to $149000.0 in 2020, then surged by 2419.46% to $3.8 million in 2021, then tumbled by 78.72% to $799000.0 in 2022.
• According to Business Quant data, Current Taxes over the past three periods registered $799000.0, $6.4 million, and $3.8 million for Q2 2022, Q1 2022, and Q4 2021 respectively.